Print
Email
Print Edition StoriesFriday, March 5, 2010
MIT's Koch Institute gets NCI funding and cancer center designation
By Mass High Tech staff
MHT talks with Grant McGimpsey, director of the WPI Center for Neuroprosthetics
Robotic surgery gains traction
MHT's Julie Donnelly: Life science startups finding investments
The National Cancer Institute showed a vote of confidence this week in providing funding to the David H. Koch Institute for Integrative Cancer Research at MIT to make it a Center for Cancer Systems Biology (CCSB).
The CCSB designation makes the Koch Institute part of NCI’s Integrative Cancer Biology Program. Douglas Lauffenburger, Koch Institute member and head of the Department of Biological Engineering, has been named principal investigator of the center.
MIT is one of 10 named Centers for Cancer Systems Biology in the U.S. to receive an undisclosed amount of funding from NCI. The centers focus on cancer systems biology as a key element in cancer research, and they will also rely on data generated from computational and mathematical models pertaining to lab and clinic work.
MIT received a $100 million donation in 2007 from MIT alum and manufacturing executive David H. Koch to establish the institute of the same name. As of the 2007 announcement, Koch, a cancer survivor, pledged more than $400 million to cancer research, education and cultural institutions, according to MIT officials. Prior to the $100 million gift, Koch had contributed money to MIT to establish the David H. Koch School of Chemical Engineering Practice.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
